Event Brief
Nov 24, 2025 at 6:01 PM ET
Ozempic Drug Fails to Quell Alzheimer’s in Trials
By The BriefBrief
Novo Nordisk's trials show semaglutide does not prevent Alzheimer's, marking a setback for brain disease treatment hopes.
WHO: Novo Nordisk
WHAT: Ozempic drug trials for Alzheimer's treatment
WHEN: Nov 23, 2025 at 7:00 PM ET
WHERE: Global
WHY: To assess the efficacy of semaglutide in preventing brain diseases
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21414 of 21414
Same format. Every time.
Continue reading — sign in or create a free account with
